Dec'22 | Dec'23 | Dec'24 | Dec'25 | Dec'26 | Dec'27 | |
---|---|---|---|---|---|---|
Revenue growth | 34.6% | 16.1% | 15.5% | 16.9% | 17.2% | 12.4% |
EPS growth | (96.3%) | N/A | (81.2%) | 33.9% | 31.6% | 5.1% |
Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue actual | $18.6M | $18.6M | $19.8M | $22.7M | $24.4M | $26.4M | $29.0M | $31.9M | $34.1M | $36.5M | $39.2M | $40.5M | $41.0M | $42.7M | $44.4M | $46.5M | $48.1M | $49.5M | $51.2M | $52.9M |
Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $30.4M | $33.0M | $35.6M | $38.6M | $40.0M | $41.8M | $44.6M | $43.9M | $45.2M | $47.6M | $50.0M | $52.2M | $54.3M |
Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.7% | 3.3% | 2.7% | 1.3% | 1.3% | 1.9% | 4.2% | 1.0% | 2.9% | 0.9% | 1.0% | 1.9% | 2.5% |
EPS actual | $0.06 | $0.08 | $0.09 | ($0.19) | $0.06 | $0.07 | $0.05 | ($3.53) | ($0.16) | ($0.03) | $0.02 | $0.01 | $0.05 | $0.01 | $0.02 | $0.01 | ($0.01) | $0.02 | $0.02 | $0.00 |
EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0.04 | $0.04 | $0.02 | $0.02 | $0.03 | $0.03 | $0.04 | $0.04 | $0.06 | $0.04 | $0.06 | $0.06 | $0.06 |
EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10,047.0% | 484.0% | 243.0% | 10.5% | 70.0% | 89.7% | 83.4% | 50.7% | 87.3% | 116.5% | 64.9% | 63.0% | 97.9% |
Enfusion, Inc. (ENFN) 1-year forward revenue growth is estimated at 16.9%.
Enfusion, Inc. (ENFN) 1-year forward EPS growth is estimated at 33.9%.
Enfusion, Inc. (ENFN) last reported EPS was $0.00, with a 97.9% miss.
Enfusion, Inc. (ENFN) had 1 beats and 9 misses in its last 10 earnings reports.